فهرست:
چکیده : 1
مقدمه: 1
فصل اول:کلیات تحقیق
1-1 : معرفی کورکامین. 4
1-2 : ترکیبات شیمیائی زردچوبه. 5
1-3 : خواص داروئی زردچوبه. 6
1-4 : نانو کریستالهای دارویی. 7
1-5 : میکروکانالها 7
1-6 : سایز ذرات : 12
1-6- 1: توصیف روشهای اندازه گیری و آنالیز توزیع سایز ذرات در یک محلول سوسپانسیون یا امولسیون : 12
1-6-2 : اندازه گیری توزیع سایز ذرات. 13
1-6-3 : طرح ریزی توزیع سایز ذرات. 14
1-6-4 : اندازه گیرنده سایز نانو ذرات. 16
1-7 : پتانسیل زتا 17
1-8 : تست XRD.. 18
1-9 : میکروسکوپ الکترونی روبشی. 19
1-9-1 : میکروسکوپ الکترونی روبشی و تاریخچه آن. 19
1-9-2 : تاریخچه. 19
1-9-3 : آشنایی با میکروسکوپ الکترونی روبشی. 20
1-9-4 : استفاده های عمومی. 20
1-9-5 : نمونه هایی از کاربرد 21
1-9-6 : نمونه اندازه ها 22
1-9-7 : آماده سازی. 22
1-9-8 : آنالیز شیمیایی در میکروسکوپ الکترونی. 23
1-9-9 : محدودیت ها 23
1-10 : خشک کن انجمادی. 24
1-11 : اسپکتروفتومتر چیست؟ 25
1-12 : تست FTIR. 26
1-13 : فرایند امواج ماوراء صوت. 27
1-14 : تست اندازه گیری مساحت سطح. 27
1-15 : فرایند رسوب حلال / ضد حلال. 28
1-16 : ضرورت استفاده از روش رسوب حلال / ضد حلال و مزایای آن. 28
فصل دوم : مروری بر ادبیات تحقیق و پیشینه تحقیق
2-1 : مروری بر تحقیقات پیشین در زمینه ی تولید دارو 33
2-2: گیاهان دارویی تولید شده با استفاده از نانو تکنولوژی. 37
2-2-1: پراکسید هیدروژن. 37
2-2-2: گیاه دارویی کتیرا در نانو فناوری. 38
3-1 : محلول سازی. 43
3-2 : سورفاکتنت.. 43
3-3 : تهیه محلول کورکامین. 47
3-4 : تهیه محلول سورفاکتنت.. 49
3-5 : مراحل انجام آزمایش.. 49
فصل چهارم : نتایج و بحث
4-1: نتایج اندازه گیری سایز ذرات. 58
4-2 : نتایج اندازه گیری پتانسیل زتا 60
4-3 : نتایج تست XRD.. 62
4-4 : نتایج تستSEM.. 64
4-5 : نتایج تست FTIR. 65
4-6 : نتایج تست اندازه گیری مساحت سطح. 69
فصل پنجم : جمع بندی و پیشنهادات
5-1 : جمع بندی. 72
2-5 : پیشنهادات 73
منبع:
A. P. V. Date.,2004. " Current Strategies for engineering drug nanoparticles" Curr. Opin. Colloid Interface Sci, pp. 222-235.
V. D. A. K. R. Patravale.,2004. "Nanosuspensions: a promising drug delivery strategy" J. Pharm. Pharmacol. 56 , p. 827–840.
R. Mu¨ller, C. Jacobs and O. Kayser.,2001. "Nanosuspensions as particulate drug formulation in therapy rationale for development and what we can expect for the future" AdV. Drug DeliVery ReV., 47,, pp. 3-19.
E. Merisko-Liversidge, G. G. Liversidge and E. R. Cooper., 2003. "Nanosizing a formulation approach for poorly-water-soluble compounds" Eur. J. Pharm. Sci., 18 (2),, pp. 113-120,
P. Anand, A. B. Kunnumakkara, R. A. Newman and B. B. Aggarwal.,2007.Mol. Pharmaceutics, 4, p. 807–818.
V. D. A. K. R. Patravale.,2004."Nanosuspensions: a promising drug delivery strategy" J. Pharm. Pharmacol. 56, p. 827–840.
J. F. Chen, C. Zheng and G. T. Chen.,1996. "Interaction of macro- and micromixing on particle size distribution in reactive precipitation" Chem. Eng. Sci., pp. 1957-1966.
G. B. G. C. S. Parsons.,1992. "The use of surface energy and polarity determinations to predict physical stability of non-polar, non-aqueous suspensions" Int. J. Pharm. 83, p. 163–170.
K. J. Brian and K. P. Robert.,2003 "Chemical processing and micromixing in confined impinging jets" AIChE J., 49 (9), pp. 2264-2282.
X. ]: Li, J. F. Chen and G. T. Chen.,1994. "Morphological configurations of material elements during turbulent mixingssexperimental study and modelling" Acta Mech. Sin., 26 (3), pp. 266-274.
J. D. R.A. Petros.,2010. "Strategies in the design of nanoparticles for therapeutic applications" Nat. Rev. Drug Discov, p. 615–627.
V. K. LaMer and R. H. Dinegar.,1950 "Theory Production and Mechanism of Formation of Monodispersed Hydrosols" J. Am. Chem. Soc., 72, pp. 4847-4854.
J. F. Chen, Y. H. Wang, F. Guo, X. M. Wang and C. Zheng.,2000."Synthesis of Nanoparticles with Novel Technology: High-Gravity Reactive Precipitation" Ind. Eng. Chem. Res., 39, pp. 948-954.
J. A. Dirksen and T. A. Ring.,1991. "Fundamentals of Crystallization: Kinetic Effects on Particle Size Distributions and Morphology" Chem. Eng. Sci. ,46, pp. 2389-2427.
E. D. F. D. M. C. N. Dudognon., 2008. "Evidence for a new crystalline phase of racemic ibuprofen" Pharm. Res. 25, p. 2853–2858.
J. C. J. P. C. Lee.,2008"Characteristics of polymers enabling nanocomminution of water-insoluble drugs" Int. J. Pharm. 355, p. 328–336.
V. D. A. K. R. Patravale., 2004 "Nanosuspensions: a promising drug delivery strategy" J. Pharm. Pharmacol. 56, p. 827–840.
D. K. C. G. A. S. S. H. M. S. P. C. Z. W. J. Wishart., 2006 "Drug bank: a comprehensive resource for in silico drug discovery and exploration" Nucleic Acids Res. 34, p. D668–D672.
T. Sugimoto., 2003 "Formation of Monodispersed Nano- and Micro Particles Controlled in Size, Shape, and Internal Structure" Chem. Eng. Technol., 26 (3), pp. 313-321.
B. L. Cushing, V. L. Kolesnichenko and C. J. O’Connor., 2004 "Recent advances in the liquid-phase syntheses of inorganic nanoparticles" Chem. ReV., 104 (9), pp. 3893-3946.
R. B. J. L. J. Williams III., 1999." Influence of micronization method on the performance of a suspension triamcinolone acetonide pressurizedmetereddose inhaler formulation" Pharm. Dev. Technol. 4, p. 167–179.
N. Rasenack and B. W. Mu¨ller., 2002."Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs" Pharm. Res., 19, pp. 1894-1900.
J. H. Hu, K. P. Johnston and R. O. Williams., 2004. "Rapid dissolving high potency danazol powders produced by spray freezing into liquid process" Int. J. Pharm., 271 (1-2), pp. 145-154.
T. L. Rogers, K. P. Johnston and Williams R. O., , 2001. "Solution Based Particle Formation of Pharmaceutical Powders by Supercritical or Compressed Fluid CO2 and Cryogenic Spray-Freezing Technologies" Drug DeV.Ind. Pharm., 27, pp. 1003-1015.
C. Jacobs, O. Kayser and R. H. Mu¨ller.,2000. "Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide" Int. J.Pharm., 196, pp. 161-164.
J. F. Chen, J. Y. Zhang, Z. G. Shen, J. Zhong and J. Yun., 2006."Preparation and Characterization of Amorphous Cefuroxime Axetil Drug Nanoparticles with Novel Technology: High-Gravity Antisolvent Precipitation" Ind. Eng. Chem. Res., 45 (25), pp. 8723-8727.
E. Reverchon, I. De Marco and G. Della Porta.,2002."Rifampicin microparticles production by supercritical antisolvent precipitation" Int. J. Pharm. 2002, 243 (1-2), pp. 83-91.
F. Francesco, H. Markus and M. Marco., 2005. "Dense Gas Antisolvent Precipitation: A Comparative Investigation of the GAS and PCA Techniques" Ind. Eng. Chem. Res., 44 (5), pp. 1502-1509.
P. H. L. S. J. B. G. P. M.A. Smith.,1997. "Widespread peroxynitrite-mediated damage in Alzheimer’s disease" J. Neurosci. 17, p. 2653–2657.
W. G. C. N. Ramakrishna.,1992."Radioprotection of hematopoietic tissues in mice by lipoic acid" Rad. Res. 130, p. 360–365.
G. L. D. M. A. M. D. P. T. T. A. El-Agamey., 2004. "Carotenoid radical chemistry and antioxidant/pro-oxidant properties" Arch. Biochem. Biophys. 430, p. 37–48.
H. G. K. H. N. M. P. M. J. L. I.D. Podmore. , 1998. "Vitamin C exhibits pro-oxidant properties" Nature 392, p. 559.
R. P.-B. D. D. R. R. L. A. E. G. E.R. Miller., 2005. "Meta-analysis: high-dosage Vitamin E supplementation may increase all-cause mortality" Ann. Intern. Med. 142, p. 37–46.
J. S. P. B. D. H. C.A. Rice-Evans., 1997."Why do we expect carotenoids to be antioxidants in vivo?" Free Rad. Res. 26, p. 381–398.
M. D. N. D. A. B.-D. J. L. Y. Sharoni., 2004. "Carotenoids and transcription" Arch. Biochem. Biophys. 430, p. 89–96.
D. L. T.A.Kennedy.,1992. "Peroxyl radical scavenging by betacarotene in lipid bilayers — effect of oxygen partial-pressure" J. Biol. Chem. 267, p. 4658–4663.
R. P.-B. D. D. R. R. L. A. E. G. E.R. Miller., 2005."Meta-analysis: high-dosage Vitamin E supplementation may increase all-cause mortality" Ann. Intern. Med. 142, p. 37–46.
R. D. B. R. V. C. F. C. G. R. Masella ., 2005. "Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes" J. Nutr. Biochem. 16, p. 577–586.
J. B. B. D. A. E. R. G. B. Z. J. Baldyga.,1995. "Jet reactor scale-up for mixing-controlled reactions" Chem. Eng. Res. Des. 73, p. 497–502.
M. S. J.R. Bourne., 1992." Fast reactions in rotor-stator mixers of different size" Chem. Eng. Process. 31, p. 285–296.
J. L. S. P. J.R. Bourne., 1992."Micromixing in static mixers—an experimental- study" Ind. Eng. Chem. Res. 31, p. 1216–1222.
M. M. C. L. K. J. R. W. X.X. Chen., 2009. "Flocculation of polymer stabilized nanocrystal suspensions to produce redispersible powders" Drug Dev. Ind. Pharm. 35, p. 283–296.
A. A.-R. C. F. P. B. M.T. Kennedy., 2008. "Atomizing into a chilled extraction solvent eliminates liquid gas from a spray-freeze drying microencapsulation process" J. Pharm. Sci. 97, p. 4459–4472.
K. J. R. W. Z.S. Yu., 2006."Spray freezing into liquid versus sprayfreeze drying: influence of atomization on protein aggregation and biological activity" Eur. J. Pharm. Sci. 27, p. 9–18.
S. G. J. C. J. C. T. R. S.D. Webb. , 2002."Surface adsorption of recombinant human interferon-gamma in lyophilized and spraylyophilized formulations" J. Pharm. Sci. 91 , p. 1474–1487.
R. L. W. R. S. T. W. F. S. Azarmi.,2008. "Formulation and in vivo evaluation of effervescent inhalable carrier particles for pulmonary delivery of nanoparticles" Drug Dev. Ind. Pharm. 34, p. 943–947.
Z. W. R. L. J. W. C. L. W. F. L.G. Sweeney., 2005."Sprayfreeze- dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery" Int. J. Pharm. 305, p. 180–185.
P. N. T. S. S. S. C. H. Y.F. Maa ., 1999. "Protein inhalation powders: spray drying vs spray freeze drying" Pharm. Res. 16, p. 249–254.
G. D. S. S. H. F. W. Abdelwahed. , 2006. "Freeze-drying of nanoparticles: formulation, process and storage considerations" Adv. Drug Deliv. Rev. 58, p. 1688–1713.
P. C. J. R. D. R. N. G. R. G. A.M. Layre., 2006. "Freeze-drying of composite core-shell nanoparticles" Drug Dev. Ind. Pharm. 32, p. 839–846.
J. P. M. M. R. W. K. J. M.E. Matteucci. , 2008. " Flocculated amorphous nanoparticles for highly supersaturated solutions" Pharm. Res. 25, p. 2477–2487.
B. B. T. R. E. E. R. W. K. J. M.E. Matteucci., 2007."Design of potent amorphous drug nanoparticles for rapid generation of highly supersaturated media" Mol. Pharm. 4, p. 782–793.
I. G. J. H. K. F. C. C. C. T. G. K. J. B. D. W. C. T. E. E. T.L. Rogers ., 2004. "Development and characterization of scable controlled precipitation process to enhance the dissolution of poorly water-soluble drugs" pharm. res. 21, pp. 2048-2057.
G. D. H. F. W. Abdelwahed ., 2006."A pilot study of freeze drying of poly (epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization" Int. J. Pharm. 309, p. 178–188.
Y. S. C. K. G. L. K. C. C. Y. Y.I. Jeong ., 2005." Effect of cryoprotectants on the reconstitution of surfactant-free nanoparticles of poly(DL-lactide-coglycolide)" J. Microencapsul. 22, p. 593–601.
O. C. M. C. M. T. C. S. M. G. R. Cavalli., 1997. " Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles" Int. J. Pharm. 148, p. 47–54.
G. C. H. F. J. D. F. P. S. de Chasteigner., 1996"Freeze-drying of itraconazole-loaded nanosphere suspensions: a feasibility study" Drug Dev. Res. 38, p. 116–124.
K. K. W. S. R. P. Y. Liu., 2007. " Ostwald ripening of beta-carotene nanoparticles" Phys. Rev. Lett. 98.
B. S. D. B. J. Q. N. F. H. G. S. W. W.K. Kraft., 2004."The pharmacokinetics of nebulized nanocrystal budesonide suspension in healthy volunteers" J. Clin. Pharmacol. 44, p. 67–72.
D. F. J.Z. Wang ., 1999. "General solution for diffusion controlled dissolution of spherical particles" Theory, J. Pharm. Sci. 88, p. 731–738 .
C. K. M. A. P. B. W. S. M. H. M. K. R. P. S.M. D'Addio., 2010. "Novel method for concentrating and drying polymeric nanoparticles: hydrogen bonding coacervate precipitation" Mol. Pharm. 7, p. 557–564.
K. B. R. P. H.S. Ashbaugh ., 2002. "Gelation of “catanionic” vesicles by hydrophobically modified polyelectrolytes" Colloid Polym. Sci. 280, p. 783–788.
G. L. ,. L. Lattuada. , 2003."Synthesis of Gd-DTPA-cholesterol: a new lipophilic gadolinium complex as a potential MRI contrast agent" Tetrahedron Lett. 44, p. 3893–3895.
N. S. L. L. Z. J. Y. W. K. C. L. L. M. Kakran., 2010."Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension" Int. J. Pharm. 383, p. 285–292.
S. S. J. V. N. Ventosa .,2001." Depressurization of an expanded liquid organic solution (DELOS): a new procedure for obtaining submicron- or micron-sized crystalline particles" Crystal Growth and Design, p. 299–303.
E. K. S.-D. Yeo., 2005. " Formation of polymer particles with supercritical fluids: a review" Journal of Supercritical Fluids. 34, p. 287–308.
H. C. H.-K. C. J.-F. C. J. Y. T. Hu., 2008. "Preparation of inhalable salbutamol sulphate using reactive high gravity controlled precipitation" Journal of Pharmaceutical Sciences 97, p. 944–949.
J.-X. W. Q.-A. W. J.-F. C. J. Y. ]: H. Zhao ., 2007. "Controlled liquid antisolvent precipitation of hydrophobic pharmaceutical nanoparticles in a microchannel reactor" Industrial and Engineering Chemistry Research. 46, p. 8229–8235.
J.-X. W. Z.-G. S. F. G. J.-F. C. J. Y. G.-L. Wang., 2007. "Preparation of azithromycin ultrafine particles with reactive precipitation" Chinese Journal of Process Engineering. 7, p. 802–806.
Z. S. Y. Y. J. C. J. Zhong.,2005."Preparation and characterization of uniform nanosized cephradine by combination of reactive precipitation and liquid antisolvent precipitation under high gravity environment" International Journal of Pharmaceutics 301 , pp. 286-293.